Rigel Pharmaceuticals, Inc.
Tetrazolones as a carboxylic acid bioisosteres

Last updated:

Abstract:

The present disclosure provides compounds that include a tetrazolone derivative of a carboxyl group of an active agent. This disclosure also relates to pharmaceutical compositions that include these compounds, methods of using these compounds in the treatment of various diseases and disorders, and processes for preparing these compounds.

Status:
Grant
Type:

Utility

Filling date:

8 Jun 2017

Issue date:

22 Oct 2019